$320 Million is the total value of Anson Funds Management LP's 88 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | BROADCOM LTDput | $27,399,000 | – | 155,000 | +100.0% | 8.57% | – | |
| IBM | New | INTERNATIONAL BUSINESS MACHSput | $13,279,000 | – | 80,000 | +100.0% | 4.15% | – |
| New | CIRRUS LOGIC INCput | $10,262,000 | – | 181,500 | +100.0% | 3.21% | – | |
| MSI | New | MOTOROLA SOLUTIONS INCput | $8,007,000 | – | 96,600 | +100.0% | 2.50% | – |
| New | SKYWORKS SOLUTIONS INCput | $7,466,000 | – | 100,000 | +100.0% | 2.34% | – | |
| New | ROYAL BK CDA MONTREAL QUEput | $7,448,000 | – | 110,000 | +100.0% | 2.33% | – | |
| CAT | New | CATERPILLAR INC DEL | $4,637,000 | – | 50,000 | +100.0% | 1.45% | – |
| New | INTEL CORPput | $3,627,000 | – | 100,000 | +100.0% | 1.14% | – | |
| MEIP | New | MEI PHARMA INC | $1,968,000 | – | 1,366,859 | +100.0% | 0.62% | – |
| HIHO | New | HIGHWAY HLDGS LTDord | $1,273,000 | – | 618,702 | +100.0% | 0.40% | – |
| XXII | New | 22ND CENTY GROUP INC | $1,178,000 | – | 1,080,750 | +100.0% | 0.37% | – |
| NOVN | New | NOVAN INC | $1,107,000 | – | 40,986 | +100.0% | 0.35% | – |
| SNOAW | New | SONOMA PHARMACEUTICALS INC*w exp 01/21/202 | $1,018,000 | – | 202,014 | +100.0% | 0.32% | – |
| CASC | New | CASCADIAN THERAPEUTICS INC | $988,000 | – | 229,286 | +100.0% | 0.31% | – |
| ALDW | New | ALON USA PARTNERS LPut ltdpart int | $960,000 | – | 100,000 | +100.0% | 0.30% | – |
| AUPH | New | AURINIA PHARMACEUTICALS INC | $815,000 | – | 388,008 | +100.0% | 0.26% | – |
| OVAS | New | OVASCIENCE INC | $637,000 | – | 416,297 | +100.0% | 0.20% | – |
| ARWR | New | ARROWHEAD PHARMACEUTICALS IN | $548,000 | – | 353,428 | +100.0% | 0.17% | – |
| CVRR | New | CVR REFNG LP | $520,000 | – | 50,000 | +100.0% | 0.16% | – |
| NVLS | New | NIVALIS THERAPEUTICS INC | $422,000 | – | 188,287 | +100.0% | 0.13% | – |
| ADAP | New | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $418,000 | – | 103,282 | +100.0% | 0.13% | – |
| CHMA | New | CHIASMA INC | $400,000 | – | 205,380 | +100.0% | 0.12% | – |
| VSTM | New | VERASTEM INC | $386,000 | – | 344,443 | +100.0% | 0.12% | – |
| ADVM | New | ADVERUM BIOTECHNOLOGIES INC | $373,000 | – | 128,539 | +100.0% | 0.12% | – |
| APOPW | New | CELLECT BIOTECHNOLOGY LTD*w exp 07/28/202 | $350,000 | – | 113,347 | +100.0% | 0.11% | – |
| SGMO | New | SANGAMO BIOSCIENCES INC | $306,000 | – | 100,209 | +100.0% | 0.10% | – |
| IZEA | New | IZEA INC | $301,000 | – | 66,734 | +100.0% | 0.09% | – |
| ADHD | New | ALCOBRA LTD | $300,000 | – | 142,973 | +100.0% | 0.09% | – |
| TUESQ | New | TUESDAY MORNING CORP | $295,000 | – | 54,611 | +100.0% | 0.09% | – |
| DRNA | New | DICERNA PHARMACEUTICALS INC | $287,000 | – | 99,658 | +100.0% | 0.09% | – |
| CAPN | New | CAPNIA INC | $288,000 | – | 355,497 | +100.0% | 0.09% | – |
| REFR | New | RESEARCH FRONTIERS INC | $289,000 | – | 158,937 | +100.0% | 0.09% | – |
| NVTRQ | New | NUVECTRA CORP | $283,000 | – | 56,253 | +100.0% | 0.09% | – |
| ONCS | New | ONCOSEC MED INC | $280,000 | – | 227,293 | +100.0% | 0.09% | – |
| ORPN | New | BIOBLAST PHARMA LTD | $282,000 | – | 270,793 | +100.0% | 0.09% | – |
| AEZS | New | AETERNA ZENTARIS INC | $275,000 | – | 56,800 | +100.0% | 0.09% | – |
| ECYT | New | ENDOCYTE INC | $276,000 | – | 108,426 | +100.0% | 0.09% | – |
| VTL | New | VITAL THERAPIES INC | $270,000 | – | 62,137 | +100.0% | 0.08% | – |
| APDN | New | APPLIED DNA SCIENCES INC | $266,000 | – | 143,838 | +100.0% | 0.08% | – |
| PTIE | New | PAIN THERAPEUTICS INC | $262,000 | – | 459,667 | +100.0% | 0.08% | – |
| APRI | New | APRICUS BIOSCIENCES INC | $263,000 | – | 202,475 | +100.0% | 0.08% | – |
| ABUS | New | ARBUTUS BIOPHARMA CORP | $257,000 | – | 105,085 | +100.0% | 0.08% | – |
| LOV | New | SPARK NETWORKS INC | $251,000 | – | 299,107 | +100.0% | 0.08% | – |
| UQM | New | UQM TECHNOLOGIES INC | $243,000 | – | 565,204 | +100.0% | 0.08% | – |
| IMUCW | New | IMMUNOCELLULAR THERAPEUTICS*w exp 08/12/202 | $240,000 | – | 117,188 | +100.0% | 0.08% | – |
| ISR | New | ISORAY INC | $235,000 | – | 404,895 | +100.0% | 0.07% | – |
| PSDV | New | PSIVIDA CORP | $225,000 | – | 131,463 | +100.0% | 0.07% | – |
| SBBP | New | STRONGBRIDGE BIOPHARMA PLC | $221,000 | – | 92,219 | +100.0% | 0.07% | – |
| ONTXW | New | ONCONOVA THERAPEUTICS INC*w exp 07/07/202 | $213,000 | – | 93,750 | +100.0% | 0.07% | – |
| STLY | New | STANLEY FURNITURE CO INC | $212,000 | – | 235,047 | +100.0% | 0.07% | – |
| CTHR | New | CHARLES & COLVARD LTD | $203,000 | – | 184,742 | +100.0% | 0.06% | – |
| CLSN | New | CELSION CORPORATION | $200,000 | – | 657,890 | +100.0% | 0.06% | – |
| RFIL | New | RF INDS LTD | $191,000 | – | 109,234 | +100.0% | 0.06% | – |
| FTEK | New | FUEL TECH INC | $165,000 | – | 143,845 | +100.0% | 0.05% | – |
| INVT | New | INVENTERGY GLOBAL INC | $154,000 | – | 205,149 | +100.0% | 0.05% | – |
| NBRV | New | NABRIVA THERAPEUTICS AGsponsored adr | $155,000 | – | 26,029 | +100.0% | 0.05% | – |
| JAGX | New | JAGUAR ANIMAL HEALTH INC | $135,000 | – | 188,200 | +100.0% | 0.04% | – |
| EGT | New | ENTERTAINMENT GAMING ASIA IN | $72,000 | – | 51,831 | +100.0% | 0.02% | – |
| EYES | New | SECOND SIGHT MED PRODS INC | $61,000 | – | 31,097 | +100.0% | 0.02% | – |
| CPSH | New | CPS TECHNOLOGIES CORP | $36,000 | – | 19,506 | +100.0% | 0.01% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-02-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICROSOFT CORP | 27 | Q3 2023 | 8.7% |
| BK OF AMERICA CORP | 24 | Q3 2023 | 15.9% |
| JPMORGAN CHASE & CO | 17 | Q2 2022 | 2.2% |
| MEDIGUS LTD | 17 | Q1 2023 | 0.0% |
| WISDOMTREE TR | 15 | Q2 2018 | 4.0% |
| RANDGOLD RES LTD | 15 | Q2 2018 | 3.3% |
| GRANITE REAL ESTATE INVT TR | 15 | Q3 2023 | 1.3% |
| BROOKFIELD ASSET MGMT INC | 15 | Q3 2022 | 1.3% |
| CENTRAL FD CDA LTD | 14 | Q1 2018 | 1.6% |
| MEI PHARMA INC | 14 | Q1 2023 | 1.2% |
View Anson Funds Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Appreciate Holdings, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Equity Distribution Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| GO Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| LogicMark, Inc. | February 14, 2023 | 987,399 | 9.9% |
| Model Performance Acquisition CorpSold out | February 14, 2023 | 0 | 0.0% |
| Mudrick Capital Acquisition Corp. IISold out | February 14, 2023 | 0 | 0.0% |
| View, Inc. | February 14, 2023 | 24,597,185 | 9.9% |
| Amarantus Bioscience Holdings, Inc. | April 18, 2022 | 14,176,424 | 5.0% |
| Dune Acquisition Corp | February 11, 2022 | 100,000 | 0.6% |
| PROPTECH INVESTMENT CORP. II | February 11, 2022 | 1,184,276 | 5.2% |
View Anson Funds Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-05 |
| DFAN14A | 2024-04-04 |
| 4 | 2024-02-26 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View Anson Funds Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.